PRAXIS PRECISION MEDICINES, INC. Interest Income, Other
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Interest Income, Other of $957.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-07.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2023-02-07
- PRAXIS PRECISION MEDICINES, INC. interest income, other for the quarter ending 2021-03-31 was $46.00K, a 64.06% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. interest income, other for the quarter ending 2020-03-31 was $128.00K.
- PRAXIS PRECISION MEDICINES, INC. interest income, other for fiscal 2022 was $957.00K, a 253.14% increase from fiscal 2021.
- PRAXIS PRECISION MEDICINES, INC. interest income, other for fiscal 2021 was $271.00K, a 93.57% increase from fiscal 2020.
- PRAXIS PRECISION MEDICINES, INC. interest income, other for fiscal 2020 was $140.00K, a 27.46% decline from fiscal 2019.
- PRAXIS PRECISION MEDICINES, INC. interest income, other for fiscal 2019 was $193.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 12 month |
|---|---|---|
| 2022-12-31 | $957.00K 10-K · filed 2023-02-07 | |
| 2021-12-31 | $271.00K 10-K · filed 2023-02-07 | |
| 2021-03-31 | $46.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $140.00K 10-K · filed 2022-02-28 | |
| 2020-03-31 | $128.00K 10-Q · filed 2021-05-11 | |
| 2019-12-31 | $193.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |